CN · Field Sheet
FIELD SHEET — BACOPA MFI-BACOPA-20261014-FS
Survey index / BACOPA

Bacopa.

Bacopa monnieri, Bacopa monniera, Bacopa procumbens
Bacopa monnieri, Bacopa monniera, Bacopa procumbens; memory and cognitive-performance literature.
SEALED MFI-BACOPA-20261014-FS · RELEASED 2026-10-14
SHEET FINGERPRINTMFI-BACOPA-20261014-FS
535INCLUDED
1,562EXCLUDED
87DUPLICATE
95NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,279records surveyed
535studies
28claims graded
129observations
8,156graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-10ceee49d367589fGRADE VERY_LOW
bacopa — cognition
direction BENEFIT · dose UNSPECIFIED · duration 12 weeks; 3 month; 8 weeks
Grade basis — weakest-link ceilings
MODERATEdesign
MODERATEdirectness
MODERATEextraction
LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-04e098cf7b60d929
UNSPECIFIED · HUMAN · 2021 · 12 weeks · RoB NOT_ASSESSABLE
1 endpoints
STU-1434bdbaa873c3ce
RCT · HUMAN · 2022 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
STU-39ae10bf51d15605
RCT · HUMAN · 2023 · 3 month · RoB HIGH_RISK
3 endpoints
STU-6b59cb64533cce6c
RCT · HUMAN · 2026 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
Quantitative observations
duration 12 weeks · failed extraction
duration 12 weeks · failed extraction
duration 3 month · failed extraction
Opposition screen
SCREEN · 24 candidates considered · 0 bound as opposing
SYNTHESIS SYN-3d3d9c1d78eb82 — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → epmc:34063409, epmc:36501109, epmc:37032999 · PKG aac28ca1c0a1f93e…
CLAIM · CLM-8f2a963029865e84GRADE VERY_LOW
bacopa — mood
direction BENEFIT · dose 20 mg; 500 mg · duration 12 weeks; 3 month; 30 days; 60 days
Grade basis — weakest-link ceilings
MODERATEdesign
MODERATEdirectness
MODERATEextraction
LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
4bound studies
Bound studies (4 shown of 4)
STU-1434bdbaa873c3ce
RCT · HUMAN · 2022 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
STU-2934f5b2b6875120
RCT · HUMAN · 2024 · 60 days · RoB SOME_CONCERNS
3 endpoints
STU-39ae10bf51d15605
RCT · HUMAN · 2023 · 3 month · RoB HIGH_RISK
3 endpoints
STU-fd00bb8c14ca3014
RCT · HUMAN · 2019 · 30 days · RoB SOME_CONCERNS
3 endpoints
Quantitative observations
duration 12 weeks · failed extraction
dose 20 mg · validated
duration 60 days · failed extraction
Opposition screen
SCREEN · 17 candidates considered · 0 bound as opposing
SYNTHESIS SYN-f06283a4038042 — outcome QUALITATIVE_ONLY · BENEFIT ×4 · not_assessed_quantitatively · 4 members
PROVENANCE → epmc:36501109, epmc:39626587, epmc:37032999 · PKG aac28ca1c0a1f93e…
Bounded preview — representative records only. The full release ships 28 claims and 129 observations.